CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
Original article

Lilly paid $2B upfront for vaccine biotechs; Infinimmune raises $75M

Positive
AI Analysis

Summary

Eli Lilly acquired vaccine biotechs with up to $3.8 billion in deal value including $2B upfront payment. Infinimmune raised $75M in funding.

Importance:7/10
Sentiment:
0.60
acquisitionvaccinesfinancingM&A
Related Companies

Read the original article

Published by Endpoints News on August 11, 2026 2:44 PM

Read Original